ZAQS.ORG

Monday, November 16, 2026 1:07 PM ET

CNBC - Health

Novo says Wegovy injection lowers BMI and obesity rates in children in trial

2 hours ago

Feds arrest top healthcare company official, alleging illegal drug importation

2 hours ago

Measles is surging in the U.S. — and outbreaks can cost millions

5 days ago

FDA warns of vision loss risk linked to GLP-1 drugs like Wegovy, Zepbound

5 days ago

Eli Lilly's obesity pill eases sleep apnea in late-stage trial

6 days ago

Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?

7 days ago

Could CRISPR cure rare diseases before birth? Scientists are getting closer

5 days ago

Moderna hikes 2026 sales growth outlook, smashes quarterly estimates

5 days ago

Jim Cramer says the AI trade is not going away as Nasdaq enters correction

11 days ago

CVS Health plans to split itself up. Here's why a breakup could make sense now

11 days ago

Jim Cramer says this bank stock is a buy after its post-election pullback

12 days ago

CVS falls on plans to split off drugstore business in major breakup

11 days ago

Novo shares jump as Wegovy pill sales impress, drugmaker hikes outlook

12 days ago

Pfizer hikes 2026 outlook as new products grow, taps company veteran as new CFO

12 days ago

Midterm elections could jolt stocks as Democrats look poised to sweep Congress

12 days ago

A biotech's high-stakes cancer bet just paid off and its shares doubled

13 days ago

Jim Cramer says lower oil prices are giving stocks a boost. Can it last?

13 days ago

Stocks started the week higher but ended in despair. Our take on the big reversal

13 days ago

Cramer's week ahead: Expect more volatility as tech earnings, midterms loom

16 days ago

Gen Z is ditching bars for run clubs — and finding more than friends along the way

17 days ago

A pharma major is touting an MS drug to ease patent-cliff fears

17 days ago

West Pharma: More than a GLP-1 play. The case for further upside

17 days ago

Cramer sees opportunity amid tech turmoil and predicts a holiday win for FedEx

18 days ago

Merck tops estimates, hikes profit outlook on strength of injectable Keytruda

18 days ago

Eli Lilly blows past estimates, hikes sales outlook on resilient GLP-1 demand

18 days ago

GLP-1 coverage is shrinking for 2027. Here are weight-loss options for workers

18 days ago

Measles resurgence exposes deeper weaknesses in U.S. public health, experts say

19 days ago

Cramer: I asked tech insiders what to buy. They surprisingly said this drug stock

20 days ago

Amgen says drug combo slashes risk of death by 58% in patients with lung cancer

21 days ago

Doctors call Moderna, Merck's cancer vaccine data a major advancement

23 days ago

Moderna shares plunge after cancer vaccine data leaks — despite positive results

24 days ago

New bipartisan bill aims to speed up clinical trials for rare disease treatments

25 days ago